ASCO Recommends Against Routine Adjuvant Chemo For Stage II Colon Cancer
Exercise Improves Function, Symptoms Of Cancer Survivors, AHRQ Report Finds
Guideline Adherence Improves Early Breast Cancer Survival
Chemosensitivity, Resistance Assays Not Ready For Clinic, ASCO Tech Assessment Says
FDA Approves Taxotere For Node+ Breast Cancer
FDA Approves Lilly’s Alimta For Metastatic NSCLC
Reduced Risk of Metastasis When Screening Finds Cancer
Ellence Has Lower Risk Of Heart Damage, Study Finds
Modality Combo Decreases Prostate Cancer Recurrence
Hormonal Therapy Improves Prostate Cancer Survival
Study Suggests Surveillance Colonoscopies Overperformed
Trending Stories
- Anthony G. Letai to be named NCI director
The Dana-Farber and Harvard physician-scientist is an inspired choice, colleagues say - NCI releases names of members of ad hoc working group—filling the void left by BSA
- ACOG says it will no longer accept federal funding
- Trump’s FDA invents an unusual regulatory pathway to approve leucovorin for autism
Experts call the move “extremely premature” - Bhattacharya: New grant review criterion is “not political”
- Jonathan Mahler on his front-page story in the NYT Magazine on Trump’s deliberate dismantling of America’s War on Cancer